NCT01407757 Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 Status COMPLETED Phase N/A
NCT01401322 Single Agent Lenalidomide in Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia Status TERMINATED Phase PHASE2
NCT01396499 Study to Assess Safety, Tolerability and Preliminary Efficacy of BKM120, PI3K Kinase Inhibitor, With Advanced Leukemias Status COMPLETED Phase PHASE1
NCT01390402 Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG Status COMPLETED Phase PHASE2
NCT01385150 Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01383473 Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients Status COMPLETED Phase N/A
NCT01380756 Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT01378416 Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome Status COMPLETED Phase PHASE1
NCT01362452 Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells Status COMPLETED Phase PHASE1
NCT01360125 S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy Status COMPLETED Phase N/A
NCT01357655 Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923) Status TERMINATED Phase PHASE2
NCT01342289 Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide Status COMPLETED Phase PHASE1
NCT01338974 S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A
NCT01326078 Use of Lipid Emulsion or Nanoemulsion of Propofol on Children Undergoing Ambulatory Invasive Procedures. Status WITHDRAWN Phase PHASE2/PHASE3
NCT01324063 A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) Status COMPLETED Phase PHASE3
NCT01323920 Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors Status COMPLETED Phase PHASE2
NCT01321385 Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia Status COMPLETED Phase N/A